KOSPIEnergy & Power105840

Woojin

₩8,330▲ 3.74%2026-11-18 close
Market Cap
₩168.2B
Turnover
₩400M
Volume
50K
Shares out.
20.2M
PER
45.6×
PBR
0.9×
EPS
₩192
Dividend Yield
3.43%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩300 per share · Prices as of the 2026-11-18 close

01

Report overview

Nuclear instrumentation supply grows, earnings mixed

Woojin supplies core instruments for Korean-standard nuclear reactors; revenue rose for three straight years through 2025, but 2025 profit fell and quarterly net results have swung between profit and loss in 2026.

  1. 1

    Revenue rose for three consecutive years from 2023 to 2025, reaching KRW 150.4 billion in 2025 on a reported basis.

  2. 2

    Operating profit in 2025 was KRW 14.2 billion, down 12.0% year on year, and net profit attributable to controlling shareholders was KRW 8.71 billion, down 36.0%.

  3. 3

    Third-quarter 2026 revenue was KRW 33.9 billion, down 28.7% from a year earlier, and net profit attributable to controlling shareholders over the last four quarters totals KRW 3.9 billion.

  4. 4

    In February 2026 Woojin signed a KRW 8.8 billion in-core instrument purchase contract with Korea Hydro & Nuclear Power (KHNP), with delivery due by March 15, 2027.

  5. 5

    Woojin's 2026 corporate value-up plan set out a payout ratio of at least 40% and expanded R&D for small modular reactors (SMRs).

02

Business structure

Woojin makes precision industrial instruments. Its business segments comprise nuclear instrumentation, automation devices, CMS, flow meters and systems, and advanced materials.

Nuclear instrumentation covers devices that measure fission rate inside the reactor core, control rod position and coolant temperature, and the company is reported to supply four core instruments used in Korean standard reactors.

Domestic media have described Woojin as the only domestic supplier of nuclear instrumentation.

Kiwoom Securities said in a March 2026 report that the four core instruments are supplied to 22 reactors in Korea and abroad, including Saeul Units 3 and 4, and that higher reactor utilization would raise demand for instrument replacement. Segment shares differ by data provider.

One source put the 2026 second-quarter revenue mix at 83% temperature sensors and instrumentation, 9% nuclear and 8% plant, while another placed nuclear in the mid-20% range, so segment weights should be read against each source's classification.

The competitive landscape is described as an oligopoly with high technical barriers and quality competition centered on safety. Industrial instruments and automation devices are more exposed to facility investment cycles than nuclear work is. The company is also developing instruments for small modular reactors.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩47.6B₩9.8B20.7%
2025Q4₩40.7B₩1.2B2.9%
2026Q1₩37.2B₩5B13.4%
2026Q2₩30.9B₩800M2.6%
2026Q3₩33.9B₩2.4B7.1%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩124.1B₩11.9B₩9.5B9.6%6.1%28.6%
2023₩129.1B₩15.4B₩11.7B11.9%6.9%21.8%
2024₩140.7B₩16.1B₩13.6B11.4%7.2%19.0%
2025₩150.4B₩14.2B₩8.7B9.4%4.4%23.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a DART-reported basis, annual revenue went from KRW 124.1 billion in 2022 to KRW 129.1 billion in 2023 (up 4.0%), KRW 140.7 billion in 2024 (up 9.0%) and KRW 150.4 billion in 2025 (up 6.9%), rising for three consecutive years from 2023 to 2025.

Operating profit rose from KRW 11.9 billion in 2022 to KRW 15.4 billion in 2023 (up 29.2%) and KRW 16.1 billion in 2024 (up 4.8%), making 2024 the largest year of 2022 to 2025. Operating profit in 2025 was KRW 14.2 billion, down 12.0%, so profit fell even as revenue grew.

The operating margin was 9.6% in 2022, 11.9% in 2023, 11.4% in 2024 and 9.4% in 2025. Net profit attributable to controlling shareholders peaked at KRW 13.6 billion in 2024 (up 16.6%) and was lowest in 2025 at KRW 8.71 billion (down 36.0%).

Net profit including non-controlling interests was KRW 16.8 billion in 2024 and KRW 11.1 billion in 2025, a different figure from the controlling-shareholder measure. Operating cash flow fell from KRW 17.6 billion in 2023 to KRW 11.4 billion in 2024 and turned negative at -KRW 2.06 billion in 2025.

Quarterly results show the same pattern: revenue peaked at KRW 47.6 billion in the third quarter of 2025 with operating profit of KRW 9.83 billion, then fell to KRW 40.7 billion with operating profit of KRW 1.2 billion in the fourth quarter, when net profit attributable to controlling shareholders swung to a loss of KRW 885 million.

The first quarter of 2026 recovered to revenue of KRW 37.2 billion, operating profit of KRW 5 billion and controlling-shareholder net profit of KRW 3.95 billion, while the second quarter brought revenue of KRW 30.9 billion, operating profit of KRW 814 million and a controlling-shareholder net loss of KRW 634 million.

Third-quarter 2026 revenue of KRW 33.9 billion rose 9.7% from the prior quarter but fell 28.7% from a year earlier, operating profit of KRW 2.39 billion fell 75.7% year on year, and controlling-shareholder net profit of KRW 1.47 billion fell 83.8%.

Net profit attributable to controlling shareholders over the last four quarters totals KRW 3.9 billion. The detailed causes of quarterly swings should be read together with segment profitability and delivery timing.

05

Industry analysis

Demand for nuclear instrumentation moves with the number of operating reactors and policy direction. After President Lee Jae-myung referred to the need for nuclear power in January 2026, Woojin's share price rose, and at that time the company was introduced as the only domestic nuclear instrumentation supplier.

The February 2026 KHNP contract is a first purchase agreement for in-core instruments for O/H work on standard reactors in 2027. Media have reported that a plan to build eight large reactors in the United States is under review as part of Korea's US investment projects, but the plan remains at the review stage.

Kiwoom Securities expects SMRs to need more instruments per megawatt than large reactors. The same report said Woojin has secured supply capability for third-and-a-half-generation SMR instruments and is taking part in government projects on innovative SMRs (i-SMR).

Doosan Enerbility, a key customer, targets starting construction of a dedicated SMR plant in 2026 and completing it in 2028, so the medium-term supply structure is expected to take clearer shape around that time.

New reactor construction and replacement demand at operating reactors are both cited as sources of instrument demand. Industrial instruments and automation devices carry a different sensitivity to economic conditions than nuclear work does.

Relative to peers, the company's position is a narrow but high-barrier niche of supplying the four core instruments for Korean standard reactors.

06

Outlook

The core of Woojin's 2026 corporate value-up plan is a larger share of high value-added revenue, R&D investment in SMRs, and maintaining a payout ratio of at least 40%.

The KHNP contract disclosed on February 26, 2026 is worth KRW 8.83 billion, equal to 6.27% of the most recent revenue, with delivery due from December 6, 2026 to March 15, 2027. How this delivery is recognized in early-2027 results is the next checkpoint.

Kiwoom Securities expects steady earnings growth as operating reactors expand and utilization rises, and it did not present an investment rating or target price.

On SMRs, Woojin is developing instrumentation technology in the i-SMR project, and the 2028 completion target for Doosan Enerbility's dedicated SMR plant marks an important point for the supply structure.

The review of large US reactor construction depends on the progress of US investment projects, and the volume Woojin could win has not been disclosed. Third-quarter 2026 operating profit fell to KRW 2.39 billion, so whether the operating margin recovers in the next regular report is the key earnings checkpoint.

On dividends, the next check is how the 40%-or-higher payout policy is applied to the fiscal 2026 dividend decision.

07

Valuation

PER
45.6×
PBR
0.9×
ROE
2.0%
EPS
₩192
BPS
₩9,746
Dividend per share
₩300

Valuation is easier to read when split into an earnings lens and an asset lens. Net profit attributable to controlling shareholders over the last four quarters totals KRW 3.9 billion, so earnings-based multiples are higher than in years when profit held near 2024 levels.

By contrast, the price-to-book ratio is below 1x, meaning the share price sits close to net asset value measured against controlling-shareholder equity of KRW 198.7 billion at end-2025.

Total equity was KRW 241.8 billion and total liabilities KRW 56.2 billion at end-2025, with a debt ratio of 23.2%, so the balance sheet remains comparatively conservative against recent years. The central contrast is a high earnings multiple alongside a low asset multiple.

A payout ratio of at least 40% sets the reference point for dividends. Operating cash flow turned negative in 2025 and quarterly profit has swung sharply in 2026, so multiple interpretation should be read alongside whether earnings recover in the next regular report.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Installed base in nuclear instrumentation

Kiwoom Securities said in a March 2026 report that Woojin is the only domestic supplier of the four core instruments for Korean standard reactors and supplies 22 reactors at home and abroad. The same report expects instrument replacement demand to rise as operating reactors increase and utilization climbs. This installed base is cited as support for earnings stability.

Secured SMR instrumentation capability

Kiwoom Securities expects SMRs to need more instruments per megawatt than large reactors. Woojin has secured supply capability for third-and-a-half-generation SMR instruments and takes part in the government i-SMR project.

A key customer, Doosan Enerbility, targets a dedicated SMR plant, which could widen medium-term supply opportunities.

Shareholder return policy codified

In its 2026 corporate value-up plan, the company stated a core policy of keeping the payout ratio at 40% or higher. Edaily reported that the company reached record revenue in 2025 and then raised dividends and bought back and retired treasury shares. If the policy holds, it gives a reference point for shareholder returns even during earnings swings.

09

Bear factors

Weaker earnings power

Third-quarter 2026 operating profit of KRW 2.39 billion was down 75.7% from a year earlier. Profit did not grow in step with three years of revenue growth, which is the starting point of the bearish case.

Declining quarterly revenue trend

Second-quarter 2026 revenue of KRW 30.9 billion fell 17.0% from the prior quarter, and third-quarter revenue of KRW 33.9 billion was down 28.7% year on year. The decline runs from KRW 47.6 billion in the third quarter of 2025 into 2026. Whether nuclear instrument supply growth can offset the smaller revenue base is the open question.

Cash flow and quarterly losses

Operating cash flow turned negative at -KRW 2.06 billion in 2025. Net losses attributable to controlling shareholders appeared in the fourth quarter of 2025 and the second quarter of 2026.

Net profit attributable to controlling shareholders over the last four quarters totals only KRW 3.9 billion, which supports a reading of a thinner earnings base.

10

Risk factors

Policy and order dependence

Demand for nuclear instrumentation depends heavily on domestic nuclear policy and the number of operating reactors. The plan to build eight large US reactors is reported to be at the review stage, so forecasts depend on whether orders actually materialize. A change in policy direction could shift both the timing and size of new orders.

Customer and timing concentration

The KHNP contract requires delivery by March 15, 2027, and Doosan Enerbility's dedicated SMR plant targets completion in 2028. Results and medium-term supply are tied to specific customers and project schedules, so any delay could push revenue recognition back. The concentration on a small number of customers is a risk.

Quarterly earnings volatility

Quarterly losses appeared with a KRW 885 million controlling-shareholder net loss in the fourth quarter of 2025 and a KRW 634 million loss in the second quarter of 2026. The first quarter of 2026 was profitable at KRW 3.95 billion, but swings between quarters are large, which makes the annual trend harder to read.

11

What to watch next

  1. December 6, 2026 to March 15, 2027

    Delivery window for the KHNP in-core instrument contract. How deliveries progress and show up in early-2027 revenue and quarterly results is the point to check.

  2. Late March 2027

    Filing deadline for the 2026 annual report. Fourth-quarter and full-year 2026 results will be confirmed in the DART regular report, showing whether annual profit recovered after the fourth-quarter 2025 swing to loss.

  3. Around the March 2027 annual general meeting

    Timing of the dividend decision. How the payout ratio of at least 40% is applied to the fiscal 2026 dividend is the point to check.

  4. May 15, 2027

    Deadline for the first-quarter 2027 quarterly report. Whether the operating margin recovers from the third-quarter 2026 level is the point to check.

  5. 2028 (target completion)

    Target completion year for Doosan Enerbility's dedicated SMR plant. It coincides with when Woojin's SMR instrument supply structure is expected to take clearer shape.

12

Overall view

Woojin supplies core instruments for Korean standard reactors and has medium-term demand drivers in reactor operation and SMR development. Annual revenue rose for three consecutive years, from KRW 124.1 billion in 2022 to KRW 150.4 billion in 2025.

Operating profit of KRW 14.2 billion and controlling-shareholder net profit of KRW 8.71 billion in 2025 both declined, and third-quarter 2026 revenue and operating profit also fell year on year.

Net profit attributable to controlling shareholders over the last four quarters totals KRW 3.9 billion, and operating cash flow turned negative in 2025. Valuation shows a contrast between a high earnings multiple and a low asset multiple. A payout ratio of at least 40% sets the reference point for shareholder returns.

The next checkpoints are delivery of the KHNP contract, the operating margin in the 2026 annual report, and whether earnings recover in the first-quarter 2027 report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. butler.works
  2. m.thinkpool.com
  3. comp.wisereport.co.kr
  4. alphasquare.co.kr
  5. edaily.co.kr
  6. k5.co.kr
  7. asp01.fnguide.com
  8. comp.fnguide.com
  9. etoday.co.kr
  10. pinpointnews.co.kr
  11. edaily.co.kr
  12. edaily.co.kr
  13. news.nate.com
  14. newspim.com
  15. newspim.com
  16. m.news.nate.com
  17. digitaltoday.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis